Home>>Signaling Pathways>> Apoptosis>> Other Apoptosis>>Rotenone

Rotenone (Synonyms: Nicouline, NSC 8505, NSC 26258, Tubatoxin)

Catalog No.GC16775

Rotenone is a mitochondrial electron transport chain complex I inhibitor that can induce apoptosis by enhancing the production of mitochondrial reactive oxygen species.

Products are for research use only. Not for human use. We do not sell to patients.

Rotenone Chemical Structure

Cas No.: 83-79-4

Size Price Stock Qty
10mM (in 1mL DMSO)
$35.00
In stock
500mg
$28.00
In stock
1g
$39.00
In stock
5g
$77.00
In stock

Tel:(909) 407-4943 Email: sales@glpbio.com


Customer Reviews

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Product has been cited by 3 publications

Description of Rotenone

Rotenone is a mitochondrial electron transport chain complex I inhibitor that can induce apoptosis by enhancing the production of mitochondrial reactive oxygen species.

HL-60 cells were treated with rotenone (1 μ m ; 36 h) approximately 50% of HL-60 cells showed chromatin condensation and nuclear fragmentation under confocal microscopy[1].Rotenone(1μM/10 nM/100 nM;24-48h) causes dose-dependent cell death in SK-N-MC neuroblastoma cells[3].

Rotenone (2.5 mg/kg/day) for 4 weeks decreased the number of tyrosine hydroxylase (TH)-positive dopaminergic neurons in the SNpc and signal intensity of TH in the striatum[2]. In the renal ischemia-reperfusion model, Rotenone(200ppm;3weeks) can protect renal tubules, block renal fibrosis, reduce inflammation and apoptosis, and improve mitochondrial abnormalities[4].

References:
[1]. Li N, Ragheb K, Lawler G, Sturgis J, Rajwa B, Melendez JA, Robinson JP. Mitochondrial complex I inhibitor rotenone induces apoptosis through enhancing mitochondrial reactive oxygen species production. J Biol Chem. 2003 Mar 7;278(10):8516-25.
[2]. Miyazaki I, Isooka N, Imafuku F, Sun J, Kikuoka R, Furukawa C, Asanuma M. Chronic Systemic Exposure to Low-Dose Rotenone Induced Central and Peripheral Neuropathology and Motor Deficits in Mice: Reproducible Animal Model of Parkinson's Disease. Int J Mol Sci. 2020 May 4;21(9):3254.
[3] Sherer TB, Betarbet R, Testa CM, Seo BB, Richardson JR, Kim JH, Miller GW, Yagi T, Matsuno-Yagi A, Greenamyre JT. Mechanism of toxicity in rotenone models of Parkinson's disease. J Neurosci. 2003 Nov 26;23(34):10756-64.
[4] Zhang W, Sha Y, Wei K, Wu C, Ding D, Yang Y, Zhu C, Zhang Y, Ding G, Zhang A, Jia Z, Huang S. Rotenone ameliorates chronic renal injury caused by acute ischemia/reperfusion. Oncotarget. 2018 May 11;9(36):24199-24208.

Protocol of Rotenone

Cell experiment [1]:

Cell lines

HL-60 cells

Preparation Method

HL-60 cells were treated with rotenone(1 μM ) for 36h.

Reaction Conditions

Rotenone :1 μM ;36 h

Applications

HL-60 cells were treated with rotenone (1 μM ; 36 h) approximately 50% of HL-60 cells showed chromatin condensation and nuclear fragmentation under confocal microscopy.
Animal experiment [2]:

Animal models

Pakanmori(PD) modle

Preparation Method

Male C57BL/6J mice were injected subcutaneously with rotenone (2.5 mg/kg/day) for 4 weeks using an osmotic mini pump.

Dosage form

Rotenone(2.5 mg/kg/day);4 weeks;sc

Applications

Chronic subcutaneous treatment with a low dose of rotenone (2.5 mg/kg/day) for 4 weeks decreased the number of tyrosine hydroxylase (TH)-positive dopaminergic neurons in the SNpc and signal intensity of TH in the striatum.

References:

[1]. Li N, Ragheb K, Lawler G, Sturgis J, Rajwa B, Melendez JA, Robinson JP. Mitochondrial complex I inhibitor rotenone induces apoptosis through enhancing mitochondrial reactive oxygen species production. J Biol Chem. 2003 Mar 7;278(10):8516-25.

[2]. Miyazaki I, Isooka N, Imafuku F, Sun J, Kikuoka R, Furukawa C, Asanuma M. Chronic Systemic Exposure to Low-Dose Rotenone Induced Central and Peripheral Neuropathology and Motor Deficits in Mice: Reproducible Animal Model of Parkinson's Disease. Int J Mol Sci. 2020 May 4;21(9):3254.

Chemical Properties of Rotenone

Cas No. 83-79-4 SDF
Synonyms Nicouline, NSC 8505, NSC 26258, Tubatoxin
Chemical Name (2R,6aR,12aS)-8,9-dimethoxy-2-(prop-1-en-2-yl)-1,2,12,12a-tetrahydrochromeno[3,4-b]furo[2,3-h]chromen-6(6aH)-one
Canonical SMILES O=C1[C@H](C2=CC(OC)=C3OC)[C@@H](COC2=C3)OC4=C1C=CC5=C4C[C@H](C(C)=C)O5
Formula C23H22O6 M.Wt 394.42
Solubility ≥ 77.6mg/mL in DMSO Storage Store at 4°C, stored under nitrogen
General tips Please select the appropriate solvent to prepare the stock solution according to the solubility of the product in different solvents; once the solution is prepared, please store it in separate packages to avoid product failure caused by repeated freezing and thawing.Storage method and period of the stock solution: When stored at -80°C, please use it within 6 months; when stored at -20°C, please use it within 1 month.
To increase solubility, heat the tube to 37°C and then oscillate in an ultrasonic bath for some time.
Shipping Condition Evaluation sample solution: shipped with blue ice. All other sizes available: with RT, or with Blue Ice upon request.

Complete Stock Solution Preparation Table of Rotenone

Prepare stock solution
1 mg 5 mg 10 mg
1 mM 2.5354 mL 12.6768 mL 25.3537 mL
5 mM 0.5071 mL 2.5354 mL 5.0707 mL
10 mM 0.2535 mL 1.2677 mL 2.5354 mL
  • Molarity Calculator

  • Dilution Calculator

  • Molecular Weight Calculator

Mass
=
Concentration
x
Volume
x
MW*
 
 
 
**When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and MSDS / CoA (available online).

Calculate

In vivo Formulation Calculator (Clear solution) of Rotenone

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)

mg/kg g μL

Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO % % Tween 80 % ddH2O
%DMSO %

Calculation results:

Working concentration: mg/ml;

Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )

Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.

Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.

Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such as vortex, ultrasound or hot water bath can be used to aid dissolving.
3. All of the above co-solvents are available for purchase on the GlpBio website.

Product Documents

Quality Control & SDS

View current batch:

Related Video of Rotenone

    Rotenone-GlpBio

Reviews

Review for Rotenone

Average Rating: 5 ★★★★★ (Based on Reviews and 38 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Rotenone

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.